The Rising Single Use Downstream Bioprocessing Market Is Driven By Cost Efficiency

By Author: colin
Total Articles: 166
Comment this article

The single use downstream bioprocessing market involves essential products that aid in the effective separation, purification and isolation of biotherapeutic products from biological sources in the biopharmaceutical industry. Some key products include cartridges, syringe filters, depth filters, inline sterile filters and other single-use equipment that provide sterile samples and protect individuals from exposure to dangerous pathogens during final drug processing. The growing preference for single-use technologies has helped reduce processing times and equipment costs compared to traditional stainless steel-based biomanufacturing methods.

The Single use downstream bioprocessing Market is estimated to be valued at US$ 1.51 Bn in 2024 and is expected to exhibit a CAGR of 15% over the forecast period 2024-2031.

Key Takeaways

Key players operating in the single use downstream bioprocessing are 3M, Agilitech, CPC (Colder Products Company), Cytiva Lifesciences, Pall Corporation and Among Others. These players are focused on developing innovative single-use products and systems to aid biomanufacturing processes.

The ...
... single use downstream bioprocessing market is witnessing growing demand due to the expanding biopharmaceutical industry worldwide and increasing R&D investments in cell and gene therapies. Biologics have become the major focus area for drug development and this is fueling adoption of single-use technologies.

Global players are expanding their production capacities and enhancing their product portfolios through acquisitions and partnerships to strengthen their presence across key markets like North America, Europe, Asia Pacific and Rest of the world regions. This is helping increase access to single use bioprocessing technologies.

Market Drivers

The major market driver for the single use downstream bioprocessing market is the cost efficiency offered compared to traditional stainless-steel based systems. Single-use products reduce cleaning and sterilization requirements between batches, enabling faster manufacturing turnaround times. They help minimize energy, water and labor costs associated with cleaning and autoclaving of large steel assets. This has boosted their popularity among biopharma companies.

Impact of geopolitical situation on Single Use Downstream Bioprocessing market growth
The current geopolitical landscape presents both challenges and opportunities for the single use downstream bioprocessing market. Rising tensions between major global powers are disrupting supply chains and trade relations across borders. This has made manufacturers more reliant on local production capabilities to ensure continuity of supplies. Overdependence on any single region also increases vulnerability to policy changes or conflicts. To address these risks, companies are diversifying manufacturing footprint and sourcing arrangements across multiple geographies. New facility set ups in strategically important locations help de-risk supply and get close to emerging customer bases.

Geopolitical events like the Russia-Ukraine conflict are impacting energy prices worldwide. Rising inflation puts pressure on disposal personal income and healthcare budgets. This may slow market adoption in the short-run. However, single use systems offer significant cost advantages over traditional stainless steel options which provide resilience. Their decentralized, modular nature also enhances flexibility to optimize facility footprints based on demand fluctuations. To sustain growth, the industry needs to demonstrate tangible cost and time savings to customers through digitalization and smart manufacturing. Partnerships across the value chain will help minimize disruptions from geopolitical instability.

Geographical Regions With High Market Concentration

Currently, North America accounts for the largest share of the single use downstream bioprocessing market, both in terms of value and volume. This is attributed to substantial R&D investments and a well-established biopharma industry in the US. Asia Pacific is expected to be the fastest growing regional market during the forecast period. This growth can be attributed to rising biosimilars demand, increasing healthcare expenditures, and expanding biologics manufacturing capabilities in China, India, and South Korea.

Fastest Growing Region

Asia Pacific is poised to be the fastest growing region for the single use downstream bioprocessing market during the forecast period. Major factors driving the growth include rising healthcare expenditure, increasing outsourcing of biologics production to Asian contract manufacturers, and favorable regulatory environment supporting biosimilars commercialization. Countries like China and India offer lower manufacturing costs and a skilled workforce to appeal to global pharmaceutical companies looking to expand their low-cost production footprint. Investments in biotech parks and initiatives to boost indigenous biopharma innovation are also boosting regional growth.

Get more insights on this topic: https://uconnect.ae/read-blog/109801

Author Bio:

Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163 )

What Are The Key Data Covered In This Single Use Downstream Bioprocessing Market Report?

:- Market CAGR throughout the predicted period

:- Comprehensive information on the aspects that will drive the Single Use Downstream Bioprocessing's growth between 2024 and 2031.

:- Accurate calculation of the size of the Single Use Downstream Bioprocessing and its contribution to the market, with emphasis on the parent market

:- Realistic forecasts of future trends and changes in consumer behaviour

:- Single Use Downstream Bioprocessing Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa

:- A complete examination of the market's competitive landscape, as well as extensive information on vendors

:- Detailed examination of the factors that will impede the expansion of Single Use Downstream Bioprocessing vendors

FAQ’s

Q.1 What are the main factors influencing the Single Use Downstream Bioprocessing?

Q.2 Which companies are the major sources in this industry?

Q.3 What are the market’s opportunities, risks, and general structure?

Q.4 Which of the top Single Use Downstream Bioprocessing companies compare in terms of sales, revenue, and prices?

Q.5 Which businesses serve as the Single Use Downstream Bioprocessing’s distributors, traders, and dealers?

Q.6 How are market types and applications and deals, revenue, and value explored?

Q.7 What does a business area’s assessment of agreements, income, and value implicate?

*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it